(2026) -
Chronological (1234 items)
(All links open in new tab)
| Jul 30, 2026 |
Covering Medical Marijuana Through Workers’ Compensation Can Improve Health And Reduce Opioid Use, Government Study Suggests
Covering the costs of medical marijuana through workers’ compensation could be a “viable” option that improves health outcomes and leads to voluntary reductions in opioid use, according to a study led by Colorado state officials. |
|---|---|
| Jul 30, 2026 |
Study: Businesses Perform Better in States with Medical Cannabis Access
A new study from University of Iowa researchers suggests that businesses do better in states that have legalized medical cannabis. The study analyzed the financial results of more than 13,000 publicly traded companies from 2001 to 2022 found that corporate valuation increased in 21 of 38 states that allowed medical cannabis access. |
| Jul 30, 2026 |
How Canada became Europe’s weed dealer
A July 24 headline in London’s Daily Telegraph declared that the unintended consequences of Canada’s legalization of marijuana are turning Belgium into a “narco state.” |
| Jul 30, 2026 |
‘Everything in Our Power’: German Patient Groups Fight to Overturn Cannabis Insurance Cuts
Earlier this month (July 10, 2026), the German government voted through a sweeping set of provisions set to significantly impact medical cannabis patients who have their prescriptions covered by their statutory health insurance. Yesterday (July 29), this was published unchanged into the Federal Gazette, seeing the ban on prescribing cannabis flower through statutory health insurance take effect on 30 July with no transitional protection, even for patients whose treatment is already approved and under way. |
| Jul 29, 2026 |
Species of Cannabis: Ruderalis and Hybrids
Although it’s not nearly as popular as indica and sativa, ruderalis has become a more prevalent species in more recent years. Originating from Central Russia, it has a similar chemical profile to hemp and contains very low levels of THC. |
| Jul 29, 2026 |
Cheech and Chong are opening a cannabis shop in Milo this weekend
If you’re in the mood for some Maui Waui with a little Labrador after a trip to Gulf Hagas, Cheech and Chong are here, man. Cheech and Chong’s newest Dispensoria will have a grand opening from 10 a.m. to 7 p.m. Saturday in Milo. You have to be at least 21 years old to join the festivities, including giveaways, raffles and other activities. The comedy duo’s brand licenses dozens of dispensaries across the country. That includes a storefront on Hammond Street in Bangor. A Dispensoria that opened on Exchange Street in Portland in 2024 closed after 13 months. |
| Jul 29, 2026 |
Pot in pop culture, through the ages
Although marijuana only recently became legal in Minnesota, it has enjoyed an outsized profile in pop culture for decades. Grass. Gold. Mary Jane. Pot. Reefer. Skunk. Tea. Whatever name you use, cannabis is back in the mainstream after being lauded for its medicinal benefits in the 1800s and being federally outlawed in 1937. Through it all, pot has assumed an outsized profile in society, influencing language, music, fashion and film. Here’s a peek at how the wacky baccy has influenced pop culture for more than 100 years. |
| Jul 29, 2026 |
Alberta-based retailer hit by Canadians drinking less booze, smoking less weed
'Canadians have less disposable income, and when they have less disposable income, they change their purchasing behaviour' Canadians eased off booze and cannabis this spring, hitting an Alberta-based retailer with falling sales and a nearly $8-million loss. Revenue at SNDL Inc, headquartered in Edmonton, fell by about four per cent to $235.8 million, according to second-quarter results released Tuesday. |
| Jul 29, 2026 |
Calif. Tesla worker alleges company denied him job over cannabis use
Tesla CEO Elon Musk has put his cannabis use on the highest stage possible, openly smoking weed on Joe Rogan’s podcast, but according to a new lawsuit, Tesla is far from friendly to employees who use medical marijuana off the clock. |
| Jul 29, 2026 |
Delaware Governor Signs Bill To Regulate And Tax Hemp THC Drinks
Delaware’s governor has signed a bill that seeks to regulate hemp-derived THC beverages—including with an age limit, potency restrictions and taxes. Gov. Matt Meyer (D) signed HB 373 from Rep. Debra Heffernan (D) into law last week and announced the action on Tuesday. The legislation as enacted restricts sales of hemp THC drinks to people aged 21 and older. |
| Jul 29, 2026 |
The new science of cannabis and sleep
Larry Mitchell never thought much about the dreams he wasn’t having. For years, while he regularly smoked cannabis, his dreams seemed to disappear. Then, last summer, he quit. Soon afterward, his nights became populated by a vivid nocturnal world unlike anything he had experienced before. |
| Jul 29, 2026 |
Cannabis medicine vital to epilepsy care
Massachusetts voters are being tasked with evaluating the state’s experiment with legalized cannabis. The debate around this has understandably focused on youth access and public safety but ignores some of the most groundbreaking medical innovations of the past several years that risk being undermined by the repeal effort. Mirroring the rest of the country, the fastest growing group of Massachusetts’ medical cannabis users are seniors. For Massachusetts’ older residents, many of whom rely on the state’s Medicare, this vote will affect whether promising therapies are explored with evidence and medical oversight or stigmatized by misguided politics. And in no area is this care more critical than in epilepsy management. |
| Jul 28, 2026 |
National Center for Cannabis Research and Education at the University of Mississippi and Southern Sky Brands Launch CBD Sleep Study
OXFORD, Miss. and CANTON, Miss., July 28, 2026 (GLOBE NEWSWIRE) -- The National Center for Cannabis Research and Education (NCCRE) at the University of Mississippi and Southern Sky Brands have announced a collaborative clinical research initiative to evaluate the effects of cannabidiol (CBD) on sleep quality among adult participants. |
| Jul 28, 2026 |
Canadian cannabis giant SNDL claims to be world’s largest after Parallel takeover
Former lenders to Parallel, the struggling cannabis multistate operator once led by chewing-gum heir William “Beau” Wrigley, finalized their takeover of company assets this week, according to a Monday announcement. And after acquiring “certain” Parallel assets in Florida, Massachusetts and Texas, Canadian cannabis and liquor giant SNDL now claims a retail footprint of 249 licensed locations – “the largest in the world by store count,” CEO Zach George claimed in a press release Monday. |
| Jul 28, 2026 |
Big Change in the Cannabis Industry
The industry was surprised Monday with a big change in teh cannabis industry. It seems it is entering another phase of consolidation, and one of the year’s most significant deals underscores how leading multi-state operators (MSOs) are preparing for the next stage of growth. Vireo Health’s acquisition of Planet 13 brings together two respected cannabis companies with complementary strengths, creating a larger footprint across several of the country’s most valuable regulated markets. |
| Jul 28, 2026 |
Cannabis and Cancer: What We Know, What We Suspect, and What Nobody Can Prove Yet
Key Takeaways -The evidence for cannabis in cancer care is strongest for symptom management, and weakest exactly where the internet is loudest: killing tumors. -Twenty-five years of laboratory work shows cannabinoids attacking cancer cells in dishes and in mice. In humans, the entire direct anti-tumor record is two small trials. -The 2017 National Academies review found insufficient evidence either to support or refute cannabinoids as a cancer treatment. That has not changed. ARISTOCRAT, a Phase 2 trial in the UK with overall survival as its primary endpoint, is the study that could move the question. It is still recruiting. -Rick Simpson gave his recipe away and never sold the oil. The cure claim attached to it still has no scientific evidence behind it, and rests on a lesion a surgeon had already removed. |
| Jul 28, 2026 |
Israel Closes Anti-Dumping Investigation Into Canadian Cannabis Due to Procedural Error, For Now
Israel has closed its newest investigation into Canadian allegations of dumping of cannabis into the Israeli market from Canada, citing human error. Israel’s Commissioner for Trade Levies and the Ministry of Economy and Industry have quietly closed their new investigation into allegations of dumping of medical cannabis into the Israeli market from Canada. |
| Jul 28, 2026 |
Veterans with PTSD and chronic pain will have to pay up for pot prescriptions with new government policy
There are concerns about recent changes to how much veterans are reimbursed for medicinal cannabis. In April, Veterans Affairs Canada dropped how much it covers from $8.50 a gram to $6.00 per gram. Many veterans have reported that this change affects the way they consume cannabis through the federal reimbursement program, which has been around since 2007. |
| Jul 28, 2026 |
Canadian Cannabis Sales Reach $485 Million in May 2026
Canada sold $485 million worth of cannabis in May 2026, according to the most recent figures from Statistics Canada. This represents a 1% year-over-year increase compared to sales in May 2025 and a 1% month-over-month decline from April 2026. National sales were down slightly from the previous month’s $490.8 million, driven by declines in Manitoba, Saskatchewan, and BC. |
| Jul 28, 2026 |
A Cannabis Flavonoid Stopped Up to 99% of Cancer-Cell Growth in Lab Tests
Standard Seed Corporation (SSC), a cutting edge AI botanical-research company, believes it has identified a compound native to cannabis which could inhibit the growth of cancer cells by over 90% in some of the most aggressive forms of cancer. Test results from the National Cancer Institute’s NCI-60 one-dose screen, a standard bank of 60 human cancer cell lines the institute has used for decades to screen candidate cancer treatments, found that SSC’s cannflavin-enriched extract stopped more than 95% of cell growth in an aggressive brain cancer and up to 99% in several leukaemias, with weaker but real effects across lung, breast, ovarian, kidney, colon and prostate. |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62
